Search Results - "Mayr, A. J."

Refine Results
  1. 1
  2. 2

    Lack of complex I is associated with oncocytic thyroid tumours by Zimmermann, F A, Mayr, J A, Neureiter, D, Feichtinger, R, Alinger, B, Jones, N D, Eder, W, Sperl, W, Kofler, B

    Published in British journal of cancer (05-05-2009)
    “…Oncocytic tumours are characterised by hyperproliferation of mitochondria. We immunohistochemically analysed all enzymes of the oxidative phosphorylation…”
    Get full text
    Journal Article
  3. 3

    Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism by MEIERHOFER, D, MAYR, J. A, FINK, K, SCHMELLER, N, KOFLER, B, SPERL, W

    Published in British journal of cancer (30-01-2006)
    “…Previously, renal cell carcinoma tissues were reported to display a marked reduction of components of the respiratory chain. To elucidate a possible…”
    Get full text
    Journal Article
  4. 4

    Leigh disease with brainstem involvement in complex I deficiency due to assembly factor NDUFAF2 defect by Herzer, M, Koch, J, Prokisch, H, Rodenburg, R, Rauscher, C, Radauer, W, Forstner, R, Pilz, P, Rolinski, B, Freisinger, P, Mayr, J A, Sperl, W

    Published in Neuropediatrics (01-02-2010)
    “…Mitochondrial NADH: ubiquinone oxidoreductase (complex I) deficiency accounts for most defects in mitochondrial oxidative phosphorylation. Pathogenic mutations…”
    Get more information
    Journal Article
  5. 5

    Oxygen distribution in microcirculation after arginine vasopressin-induced arteriolar vasoconstriction by Friesenecker, B, Tsai, A G, Dünser, M W, Mayr, A J, Martini, J, Knotzer, H, Hasibeder, W, Intaglietta, M

    “…The microvascular distribution of oxygen was studied in the arterioles and venules of the awake hamster window chamber preparation to determine the…”
    Get more information
    Journal Article
  6. 6

    Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin by Mayr, A.J, Dünser, M, Jochberger, S, Fries, D, Klingler, A, Joannidis, M, Hasibeder, W, Schobersberger, Wolfgang

    Published in Thrombosis research (01-02-2002)
    “…Background: Low-molecular-weight heparins (LMWHs) have become increasingly used to prevent thromboembolic complications in intensive care patients. Unlike in…”
    Get full text
    Journal Article
  7. 7

    Danon disease: Case report and detection of new mutation by Regelsberger, G., Höftberger, R., Pickl, W. F., Zlabinger, G. J., Körmöczi, U., Salzer-Muhar, U., Luckner, D., Bodamer, O. A., Mayr, J. A., Muss, W. H., Budka, H., Bernheimer, H.

    Published in Journal of inherited metabolic disease (01-12-2009)
    “…Summary Danon disease is an X-linked disorder resulting from mutations in the lysosome-associated membrane protein-2 ( LAMP2 ) gene. We report a male patient…”
    Get full text
    Journal Article
  8. 8

    Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I by Budde, S. M. S., Heuvel, L. P. W. J., Smeets, R. J. P., Skladal, D., Mayr, J. A., Boelen, C., Petruzzella, V., Papa, S., Smeitink, J. A. M.

    Published in Journal of inherited metabolic disease (01-01-2003)
    “…A comparison of the clinical presentation, disease course and results of laboratory and imaging studies of all patients so far published with a NDUFS4 mutation…”
    Get full text
    Journal Article
  9. 9

    Congenital cataract, muscular hypotonia, developmental delay and sensorineural hearing loss associated with a defect in copper metabolism by Horváth, R., Freisinger, P., Rubio, R., Merl, T., Bax, R., Mayr, J. A., Shawan, Müller‐Höcker, J., Pongratz, D., Moller, L. B., Horn, N., Jaksch, M.

    Published in Journal of inherited metabolic disease (01-08-2005)
    “…Summary Deficiencies of different proteins involved in copper metabolism have been reported to cause human diseases. Well‐known syndromes, for example, are…”
    Get full text
    Journal Article
  10. 10

    Cardiac performance during vasopressin infusion in postcardiotomy shock by DÜNSER, M. W, MAYR, A. J, STALLINGER, A, ULMER, H, RITSCH, N, KNOTZER, H, PAJK, W, MUTZ, N. J, HASIBEDER, W. R

    Published in Intensive care medicine (01-06-2002)
    “…Arginine-vasopressin (AVP) might be a potent vasopressor agent in catecholamine-resistant postcardiotomy shock. However, its use remains experimental because…”
    Get full text
    Journal Article
  11. 11

    Arginine vasopressin and serum nitrite/nitrate concentrations in advanced vasodilatory shock by Dünser, M. W., Werner, E. R., Wenzel, V., Ulmer, H., Friesenecker, B. E., Hasibeder, W. R., Mayr, A. J.

    Published in Acta anaesthesiologica Scandinavica (01-08-2004)
    “…Background:  Arginine‐vasopressin (AVP) can successfully stabilize hemodynamics in patients with advanced vasodilatory shock. It has been suggested that…”
    Get full text
    Journal Article
  12. 12

    Mitochondrial DNA depletion in Alpers syndrome by Tesarova, M, Mayr, J A, Wenchich, L, Hansikova, H, Elleder, M, Blahova, K, Sperl, W, Zeman, J

    Published in Neuropediatrics (01-08-2004)
    “…Mitochondrial dysfunction of the energy generating system was suggested in two infants with progressive infantile poliodystrophy characterised by hypotonia,…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Craniotomy during ECMO in a severely traumatized patient by Friesenecker, B E, Peer, R, Rieder, J, Lirk, P, Knotzer, H, Hasibeder, W R, Mayr, A J, Dünser, M W

    Published in Acta neurochirurgica (01-09-2005)
    “…Extracorporeal membrane oxygenation (ECMO) can be a last resort treatment in acute respiratory distress syndrome after thoracic trauma. However, co-existent…”
    Get full text
    Journal Article
  16. 16

    Molecular medicine: pathobiochemistry as the key to personalized treatment of inherited diseases by Mayr, J A, Feichtinger, R G, Achleitner, M T, Brugger, K, Kutsam, K, Spenger, J, Koch, J, Hofbauer, P, Lagler, F B, Sperl, W, Weghuber, D, Wortmann, S B

    Published in Monatsschrift Kinderheilkunde (01-09-2021)
    “…Genetic defects are often still regarded as a life-long fate, which one has to cope with. It is true that in many cases an inherited disposition may lead to…”
    Get full text
    Journal Article
  17. 17

    MKS1 mutations cause joubert syndrome with agenesis of the corpus callosum by Bader, Ingrid, Decker, E, Mayr, J.A, Lunzer, V, Koch, J, Boltshauser, E, Sperl, W, Pietsch, P, Ertl-Wagner, B, Bolz, H, Bergmann, C, Rittinger, O

    Published in European journal of medical genetics (01-08-2016)
    “…Abstract Joubert syndrome (JS) is a clinically and genetically heterogeneous ciliopathy characterized by episodic hyperpnea and apnea, hypotonia, ataxia,…”
    Get full text
    Journal Article
  18. 18

    Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study by DÜNSER, Martin W, MAYR, Andreas J, ULMER, Hanno, KNOTZER, Hans, SUMANN, Günther, PAJK, Werner, FRIESENECKER, Barbara, HASIBEDER, Walter R

    Published in Circulation (New York, N.Y.) (13-05-2003)
    “…Vasodilatory shock is a potentially lethal complication of severe disease in critically ill patients. Currently, catecholamines are the most widely used…”
    Get full text
    Journal Article
  19. 19

    Cardiac failure and multiple organ dysfunction syndrome in a patient with endocrine adenomatosis by Dünser, M. W., Mayr, A. J., Gasser, R., Rieger, M., Friesenecker, B., Hasibeder, W. R.

    Published in Acta anaesthesiologica Scandinavica (01-10-2002)
    “…In this case report, we present the successful therapy of severe cardiac failure in pituitary adrenal insufficiency. A previously healthy 56‐year‐old‐man in…”
    Get full text
    Journal Article
  20. 20

    Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: comparison with catastrophic antiphospholipid syndrome by Wiedermann, F J, Lederer, W, Mayr, A J, Sepp, N, Herold, M, Schobersberger, W

    Published in Lupus (01-01-2003)
    “…Detection of antiphospholipid (aPL) antibodies in bronchoalveolar lavage fluid (BALF) of patients with acute respiratory distress syndrome (ARDS) suggests…”
    Get full text
    Journal Article